21.02.2014 • TopicsEgnatonEgnaton Notes plusSustainability

eJournal Egnaton Notes plus

Egnaton Notes plus 1st edition is dominated by the variety of sustainability.
Egnaton Notes plus 1st edition is dominated by the variety of sustainability.

Sustainability is influenced by acting interdisciplinary and a huge variety of single parameters. Due to the perception that single organizations or personalities are unable to perform the expertise in all necessary disciplines Egnaton describes the variety with the eJournal Egnaton Notes plus.

Egnaton Notes plus 1st edition is dominated by the variety of sustainability. All sustainability topics are handled by the work groups in a holistic way and good results may be expected in order to improve research laboratories. Against the background of further individual properties of research buildings and the technological advance there is no end of sustainability generating design processes in sight.

The articles are the result of working groups within Egnaton as well as case study of single members. They must be understood as depiction of special conditions but also as suggestions for the experienced reader with regard to feasible strategies.

Company contact







Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
19.03.2025 • TopicsStrategy

The Future of Demand for Chemicals

The chemical industry is shifting to sustainability-related products, with demand growing 4.5 times faster than conventional ones. Companies must revise their market strategies to capitalize on this opportunity.

Photo
14.05.2025 • TopicsPharma

Pharma Outlook 2025

The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.